s
IRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents Against Aggressive Brain Tumors and Acute Lymphoblastic Leukemia at AACR
04-04-2024, 15:00
ROME, April 4, 2024 /PRNewswire/ — IRBM, a leader in the field of drug discovery, announced today that it will be disclosing new data on two of its most promising internal assets at the upcoming American Association for Cancer Research (AACR) Annual Meeting occurring in San Diego, April 5-10. The data will reveal insights into […] L'articolo IRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents Against Aggressive Brain Tumors and Acute Lymphoblastic Leukemia at AACR proviene da La Ragione.
CONTINUA A LEGGERE
12
0
0
Guarda anche
La Ragione
09:43
A Chieti la Gdf intercetta pacco di droga spedito dalla Spagna
La Ragione
09:36